Cambium Bio Competitors and Similar CompaniesClear all
Cambium Bio's competitors and similar companies include InGeneron and AavantiBio.
 Cambium Bio Cambium Bio (formerly known as Regeneus) is a regenerative medicine company developing a portfolio of cell-based therapies with a focus on osteoarthritis (OA), neuropathic pain, and dermatology. |  InGeneron InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells. |  AavantiBio AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space. | |
Founding Date | Founding Date 2007 | Founding Date 2006 | Founding Date 2020 |
Type | Type Public | Type Private | Type Private |
Tags | |||
Locations | Locations Paddington, AU HQ Pymble, AU | Locations Houston, US HQ München, DE | Locations Cambridge, US HQ |
Employees | Employees N/A | Employees 16 | Employees 6 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 23m (about 7 years ago) | Latest funding round $ 107m (over 5 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 47.5m | Total funding raised $ 107m |
For sources of this data, please see the company profile
View Company Profiles
InGeneron
HQ
Houston, US
Employees
16
InGeneron is a cell therapy company that offers treatments designed to heal certain chronic conditions using a patient’s own regenerative cells.
View companyAavantiBio
HQ
Cambridge, US
Employees
6
AavantiBio is a biotechnology company dedicated to gene therapy research in the rare disease space.
View company